Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e09319fe979c0d63f50e0b9dcf132ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4b62e22f18b657a93fac87dbb273532 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14171 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10041 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14132 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-007 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1719 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-861 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0075 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
filingDate |
2018-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c33c5c5c13bd4aa464fd535e2f6e067d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_542f3fa35ec2eca903cc7697599ef931 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0b59ffc2a829b693d2e1ab13775bcc9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b796334d3c1ad0b19814ff6d97e33a7 |
publicationDate |
2020-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10786546-B2 |
titleOfInvention |
Efficient systemic treatment of dystrophic muscle pathologies |
abstract |
A composition comprising a gene therapy product for use in the treatment of a dystrophic disease in a subject, advantageously in humans, wherein:n the gene therapy product comprises a nucleic acid sequence encoding a functional microdystrophin; the composition is systemically administered. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020405810-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11535868-B2 |
priorityDate |
2014-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |